EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk Factors and Outcome in Living Kidney Donors: A Narrative Review

Lucas-Gabriel Discălicău, Cătălin Baston, Bogdan-Marian Sorohan, Oana Moldoveanu, Silviu Guler-Margaritis, Pavel-Mihai Vișinescu, Ioanel Sinescu

Kidney and Dialysis · 22.04.2026 · 6 (2) · 28

DOI: 10.3390/kidneydial6020028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney and Dialysis, online erschienen am 22.04.2026. Verfasst von Lucas-Gabriel Discălicău und 6 weiteren Autor:innen. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Candidates with cardiometabolic risk are considered for living kidney donation more frequently because of the global organ shortage. The 2017 Kidney Disease: Improving Global Outcomes (KDIGO) guidelines introduced individualized risk assessment based on composite donor profiles rather than categorical exclusion, but the long-term implications of accepting donors with potential risk factors require careful evaluation. This review synthesizes current evidence on outcomes of living kidney donors with obesity, prediabetes, hypertension, and smoking.

Methods

A literature search was conducted in PubMed/MEDLINE for studies published between 1 January 2000 and 28 February 2026, including cohort studies, registry analyses, meta-analyses, and clinical guidelines evaluating living kidney donors with obesity, smoking, prediabetes, or hypertension. Priority was given to large cohorts with long-term follow-up. Over 70 publications were included in the final synthesis. Findings were synthesized narratively by risk factors and outcomes.

Results

Obesity was associated with an 86% increased end-stage kidney disease (ESKD) risk and 32% increased 20-year mortality. Central adiposity measures outperformed body mass index (BMI) for predicting estimated glomerular filtration rate (eGFR) decline. Post-donation weight gain increased the risk for developing hypertension and diabetes. Smoking conferred a 7.5-fold chronic kidney disease (CKD) risk, with impaired compensatory renal adaptation after donation. Prediabetic donors showed comparable outcomes to normoglycemic donors, with 57.8% reverting to normoglycemia at 10 years. Pre-donation hypertension increased 15-year ESKD risk 3-fold, but absolute risk remained low. At 15 years post-donation, over 50% of the donors developed hypertension. Glucagon-like peptide-1 (GLP-1) receptor agonists reduce diabetes progression by 73–94% in at-risk populations, but prospective studies in donors are lacking.

Conclusions

Each risk factor carries quantifiable risks for individualized stratification. These risk factors usually coexist and interact. Refinement of risk prediction models, strategies for metabolic optimization and prospective evaluation of emerging pharmacologic therapies are key priorities.

Zitieren

APA

Discălicău, L., Baston, C., Sorohan, B., Moldoveanu, O., Guler-Margaritis, S., Vișinescu, P., & Sinescu, I. (2026). Risk Factors and Outcome in Living Kidney Donors: A Narrative Review. Kidney and Dialysis, 6(2), 28. https://doi.org/10.3390/kidneydial6020028

Vancouver

Discălicău L, Baston C, Sorohan B, Moldoveanu O, Guler-Margaritis S, Vișinescu P, et al. Risk Factors and Outcome in Living Kidney Donors: A Narrative Review. Kidney and Dialysis. 2026;6(2):28. doi:10.3390/kidneydial6020028

BibTeX
@article{Disclicu2026,
  author = {Discălicău, Lucas-Gabriel and Baston, Cătălin and Sorohan, Bogdan-Marian and Moldoveanu, Oana and Guler-Margaritis, Silviu and Vișinescu, Pavel-Mihai and Sinescu, Ioanel},
  title = {Risk Factors and Outcome in Living Kidney Donors: A Narrative Review},
  journal = {Kidney and Dialysis},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {28},
  doi = {10.3390/kidneydial6020028}
}
Kostenlos starten →